cPLA2
|
IV |
α (A) β (B) γ (C) δ (D) ε (E) ζ (F) |
|
60–114 |
Ser/asp |
Dennis et al., 2011; Leslie, 2015
|
cPLA2-IVα in lipid signaling |
iPLA2
|
VI |
β (A) γ (B) δ (C) ε (D) ζ (E) η (F) |
PNPLA9 PNPLA8 PNPLA6 PNPLA3 PNPLA2 PNPLA4 |
27–146 |
Ser/Asp |
Dennis et al., 2011; Ramanadham et al., 2015
|
iPLA2-VIβ in supporting focal exocytosis at the phagocytic cup |
sPLA2
|
I II III V IX X XI XII XIII XIV |
A, B A, B, C, D, E, F A, B A, B |
|
10–19 |
His/Asp |
Dennis et al., 2011; Murakami et al., 2015; Murakami, 2017
|
sPLA2-IIA, V, X, XII as antimicrobial forms at the phagocytic cup and within closed phagosomes |
LPLA2
|
XV |
|
|
45 |
Ser/His/Asp |
Dennis et al., 2011; Fisher, 2018
|
LPLA2 having bacteriocidal activity at the phagocytic cup and within phagolysosomes Also, its membrane repair mechanism |
aiPLA2
|
XVI |
|
Peroxiredoxin 6 |
25 |
Ser/His/Asp |
Fisher, 2018 |
aiPLA2regulating NOX2 assembly, and its membrane repair mechanism |
PAF-AH |
VIIA VIIB VIII |
|
Lp-PLA2, PLA2VII PAF-AH II PAF-AH I (PAFAH1B1 PAFAH1B2 PAFAH1B3) |
26–45 |
Ser/His/Asp |
Dennis et al., 2011; Karasawa and Inoue, 2015
|
Not discussed as relevant information was not found |